Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-01-11
2011-01-11
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007230, C436S501000, C436S518000
Reexamination Certificate
active
07867705
ABSTRACT:
The present specification provides, inter alia, methods of using Wnt and FZD proteins, genes, FZD and Wnt-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
REFERENCES:
patent: 6043053 (2000-03-01), Barnes et al.
patent: 6924141 (2005-08-01), Morgan et al.
patent: 2003/0165500 (2003-09-01), Rhee et al.
patent: 2004/032838 (2004-04-01), None
Katoh, “Regulation ofWNT3andWNT3AmRNAs in human cancer cell lines NT2, MCF-7, and MKN45”,International Journal of Oncology, vol. 20:373-377 (2002).
Kim et al., “Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells,” Journal of Hepatology, 48:780-791 (2008).
Aberle et al., “Cadherin-Catenin Complex: Protein Interactions and Their Implications for Cadherin Function,”Journal of Cellular Biochemistry, vol. 61:514-523 (1996).
Anna et al., “Expression of Potential β-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice,”Toxicology and Applied Pharmacology, vol. 190:135-145 (2003).
Anthony, “Hepatocellular carcinoma: an overview,”Histopathology, vol. 39:109-118 (2001).
Aoki et al., “Oncogenic transformation by β-Catenin: deletion analysis and characterization of selected target genes,”Oncogene, vol. 21:6983-6991 (2002).
Ban et al., “GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma,”Cancer Letters, vol. 199:201-208 (2003).
Bhanot et al., “A new member of thefrizzledfamily fromDrosophilafunctions as a Wingless receptor,”Nature, vol. 382:225-230 (1996).
Bièche et al., “Quantitation ofMYCGene Expression in Sporadic Breast Tumors with a Real-Time Reverse Transcription-PCR Assay,”Cancer Research, vol. 59:2759-2765 (1999).
Bradley et al., “The proto-oncogeneint-1 encodes a secreted protein associated with the extracellular matrix,”The EMBO Journal, vol. 9:1569-1575 (1990).
Cagatay et al., “p53 Mutation as a source of aberrant β-catenin accumulation in cancer cells,”Oncogene, vol. 21:7971-7980 (2002).
Calvisi et al., “Activation of β-Catenin during Hepatocarcinogenesis in Transgenic Mouse Models: Relationship to Phenotype and Tumor Grade,”Cancer Research, vol. 61:2085-2091 (2001).
Calvisi et al., “Disruption of β-Catenin Pathway or Genomic Instability Define Two Distinct Categories of Liver Cancer in Transgenic Mice,”Gastroenterology, vol. 126:1374-1386 (2004).
Candidus et al., “No Evidence for Mutations in the α- and β-Catenin Genes in Human Gastric and Breast Carcinomas,”Cancer Research, vol. 56:49-52 (1996).
Cariani et al., “Differential Expression in Insulin-like Growth Factor II mRNA in Human Primary Liver Cancers, Benign Liver Tumors, and Liver Cirrhosis,”Cancer Research, vol. 48:6844-6849 (1988).
Carloni et al., “The Integrin α6β1, Is Necessary for the Matrix-Dependent Activation of FAK and MAP Kinase and the Migration of Human Hepatocarcinoma Cells,”Hepatology, vol. 34:42-49 (2001).
Carruba et al., “Truncated Form of β-Catenin and Reduced Expression of Wild-Type Catenins Feature HepG2 Human Liver Cancer Cells,”Annals New York Academy of Sciences, vol. 886:212-216 (1999).
Caselmann et al., “Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma,”Journal of Hepatology, vol. 24:61-66 (1996).
Cha et al., “Hepatitis B Virus X Protein Is Essential for the Activation of Wnt/β-Catenin Signaling in Hepatoma Cells,”Hepatology, vol. 39:1683-1693 (2004).
Chan et al., “Evidence that Armadillo Transduces Wingless by Mediating Nuclear Export or Cytosolic Activation of Pangolin,”Cell, vol. 111:265-280 (2002).
Cheon et al., “β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds,”PNAS, vol. 99:6973-6978 (2002).
Chung, “The Genetic Basis of Colorectal Cancer: Insights into Critical Pathways of Tumorigenesis,”Gastroenterology, vol. 119:854-865 (2000).
Clevers, “Axin and hepatocellular carcinomas,”Nature Genetics, vol. 24:206-208 (2000).
Davila et al., “Hepatitis C Infection and the Increasing Incidence of Hepatocellular Carcinoma: A Population-Based Study,”Gastroenterology, vol. 127:1372-1380 (2004).
de La Coste et al., “Somatic mutations of the β-Catenin gene are frequent in mouse and human hepatocellular carcinoma,”Proc. Natl. Acad. Sci. USA, vol. 95:8847-8851 (1998).
de la Monte et al., “ATP Luminescence-Based Motility-Invasion Assay,”Biotechniques, vol. 33:98-106 (2002).
De Souza et al., “M6P/IGF2Rgene is mutated in human hepatocellular carcinomas with loss of heterozygosity,”Nature Genetics, vol. 11:447-449 (1995).
Devereux et al., “Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis,”Oncogene, vol. 18: 4726-4733 (1999).
Devereux et al., “CTNNB1Mutations and β-Catenin Protein Accumulation in Human Hepatocellular Carcinomas Associated With High Exposure to Aflatoxin B1,”Molecular Carcinogenesis, vol. 31:68-73 (2001).
Dhoot et al., “Regulation of Wnt Signaling and Embryo Patterning by an Extracellular Sulfatase,”Science, vol. 293:1663-1666 (2001).
Du et al., “Identification of Distinct Classes and Functional Domains of Wnts through Expression of Wild-Type and Chimeric Proteins inXenopusEmbryos,”Molecular and Cell Biology, vol. 15:2625-2634 (1995).
Dubois et al., “Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice,”Journal of Hepatology, vol. 13:227-239 (1991).
El-Serag et al., “Rising Incidence of Hepatocellular Carcinoma in the United States,”The New England Journal of Medicine, vol. 340:745-750 (1999).
Etiemble et al., “Liver-specific expression and high oncogenic efficiency of c-myctransgene activated by woodchuck hepatitis virus insertion,”Oncogene, vol. 9:727-737 (1994).
Fausto et al., “Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease,”Seminars in Liver Disease, vol. 19:243-252 (1999).
Feitelson et al., “Genetic mechanisms of hepatocarcinogenesis”,Oncogene, vol. 21:2593-2604 (2002).
Frith et al., “Tumors of the liver,”Pathology of Tumors in Laboratory Animals., V. Turusov and U. Mohn, editors, IARC. Lyon, France, vol. 2:223-270 (1994).
Giles et al., “Caught up in a Wnt storm: Wnt signaling in cancer,”Biochimica et Biophysica Acta, vol. 1653:1-24 (2003).
Gregorieff et al., “Expression Pattern of Wnt Signaling Components in the Adult Intestine,”Gastroenterology, vol. 129:626-638 (2005).
Hanahan et al., “The Hallmarks of Cancer,”Cell, vol. 100:57-70 (2000).
He et al., “Identification of c-MYCas a Target of the APC Pathway,”Science, vol. 281:1509-1512 (1998).
Herrmann et al., “Oncogenic Role and Specificity of Frizzled Receptor Expression in Animal Models of Hepatocellular Carcinoma,”Hepatology, vol. 38:180A (2003).
Holcombe et al., “Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma,”J. Clin. Pathol. Mol. Pathol., vol. 55:220-226 (2002).
Hommura et al., “Increased Expression of β-Catenin Predicts Better Prognosis in Nonsmall Cell Lung Carcinomas,”Cancer, vol. 94:752-758 (2002).
Hsu et al., “β-Catenin Mutations Are Associated with a Subset of Low-Stage Hepatocellular Carcinoma Negative for H
De La Monte Suzanne M.
Merle Philippe
Wands Jack R.
Fish & Richardson P.C.
Rhode Island Hospital, a Lifespan-Partner
Yu Misook
LandOfFree
Frizzled proteins and detection and treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Frizzled proteins and detection and treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Frizzled proteins and detection and treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639446